Share
Marika Murto
LEO Pharma, a global leader in medical dermatology, has appointed Marika Murto, PhD, as Senior Vice President of Global Product Strategy.
She will also become a member of the company’s Global Leadership Team, further strengthening LEO Pharma’s strategic capabilities at a global level.
Marika Murto joins LEO Pharma from Amgen, where she most recently served as Associate Vice President and U.S. Commercial Lead for Bone Health. In this role, she was responsible for shaping strategic brand positioning, driving commercial performance, and fostering strong cross-functional collaboration across the organization. Her tenure at Amgen included several senior leadership roles spanning both global and regional responsibilities.
During her career at Amgen, Marika held key positions such as General Manager for the Netherlands, Global Product Team Lead for Bone Health, and Country Director for Finland. These roles enabled her to build deep expertise in portfolio management, product lifecycle strategy, and market access across diverse healthcare systems.
Prior to Amgen, she held senior commercial roles at Pfizer and Roche, where she worked across multiple therapeutic areas including oncology, vaccines, specialty medicines, and broader portfolio strategy.
With her strong scientific background and extensive global leadership experience, Marika brings a unique ability to translate science into impactful product strategies. In her new role, she will be instrumental in shaping the future direction of LEO Pharma’s product portfolio, ensuring it remains aligned with patient needs while supporting sustainable, long-term growth for the company.
Marika Murto will officially join LEO Pharma as Senior Vice President of Global Product Strategy on February 1, 2026.
